In contrast to anti-CTLA-4 monotherapy, L. acidophilus lysates attenuated body weight loss and the combined administration significantly protected mice against CRC development, suggesting an enhancement of anti-CTLA-4 antitumor activity. Here, CTLA4 is linked to colorectal carcinoma.